Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the transaction, the chief executive officer owned 3,929,183 shares in the company, valued at $786,465,269.28. This trade represents a 3.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jitendra Mohan also recently made the following trade(s):
- On Monday, April 20th, Jitendra Mohan sold 10,188 shares of Astera Labs stock. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60.
- On Friday, April 17th, Jitendra Mohan sold 325,693 shares of Astera Labs stock. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02.
- On Wednesday, April 15th, Jitendra Mohan sold 2,967 shares of Astera Labs stock. The shares were sold at an average price of $174.60, for a total value of $518,038.20.
- On Friday, April 10th, Jitendra Mohan sold 123,750 shares of Astera Labs stock. The shares were sold at an average price of $149.68, for a total value of $18,522,900.00.
- On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00.
- On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51.
Astera Labs Stock Performance
ALAB opened at $204.42 on Wednesday. The stock has a market cap of $35.04 billion, a price-to-earnings ratio of 138.12, a P/E/G ratio of 3.42 and a beta of 3.35. The stock’s 50 day moving average price is $148.57 and its 200-day moving average price is $155.00. Astera Labs, Inc. has a one year low of $81.14 and a one year high of $262.90.
Astera Labs News Summary
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Astera Labs was highlighted as a company that could help solve a major AI infrastructure bottleneck, reinforcing its role in high-speed connectivity for AI data centers. Astera Labs (ALAB) Touted To Solve Big AI Bottleneck
- Positive Sentiment: Zacks said demand remains strong for Astera Labs’ Scorpio portfolio, which already contributes more than one-third of revenue and could become the company’s largest product line by 2026. Astera Labs Rides on Strong Scorpio Portfolio: What Lies Ahead?
- Positive Sentiment: Needham raised its price target to $260 from $220 and kept a Buy rating, citing another strong beat-and-raise quarter, which supports bullish sentiment around ALAB. Is Astera Labs. (ALAB) the Best American Semiconductor Stock to Buy According to Analysts?
- Positive Sentiment: The stock was also featured as a potential beneficiary of the AI inference boom, keeping attention on Astera Labs’ growth tied to AI spending. 5 Stocks Positioned to Benefit From the AI Inference Boom (ALAB)
- Neutral Sentiment: Astera Labs announced participation in several upcoming financial conferences, which is a routine investor-relations update and not a major fundamental catalyst. Astera Labs Announces Second Quarter 2026 Financial Conference Participation
- Negative Sentiment: CEO Jitendra Mohan, COO Sanjay Gajendra, and director Stefan A. Dyckerhoff all sold shares in recent pre-arranged 10b5-1 transactions, which can pressure sentiment even though the sales were scheduled in advance. Astera Labs (NASDAQ:ALAB) CEO Jitendra Mohan Sells 139,951 Shares of Stock
- Negative Sentiment: Artisan Mid Cap Fund reduced its holdings in Astera Labs, adding another sign of institutional profit-taking or caution after the stock’s strong run. Here’s Why Artisan Mid Cap Fund Reduced Its Holdings in Astera Labs (ALAB)
Institutional Trading of Astera Labs
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Lido Advisors LLC lifted its position in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after acquiring an additional 57 shares during the period. Perigon Wealth Management LLC lifted its position in Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after acquiring an additional 73 shares during the period. Clearstead Advisors LLC lifted its position in Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the period. Sound Income Strategies LLC lifted its position in Astera Labs by 9.2% during the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after acquiring an additional 76 shares during the period. Finally, Venturi Wealth Management LLC lifted its position in Astera Labs by 2.6% during the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after acquiring an additional 84 shares during the period. Institutional investors own 60.47% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the company. Needham & Company LLC increased their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Rothschild & Co Redburn started coverage on Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Citigroup increased their target price on shares of Astera Labs from $200.00 to $245.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Roth Mkm reiterated a “buy” rating and set a $275.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Finally, Barclays increased their target price on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Fifteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $229.65.
Read Our Latest Research Report on Astera Labs
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories
- Five stocks we like better than Astera Labs
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
